By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, … Continue reading A Journey of Endurance
Financial Chronicle: Big Interview: Biocon CMD Kiran Mazumdar-Shaw spoke to FC on a range of topics, including women as entrepreneurs, philanthropy, affordable healthcare, citizen activism etc. Here’s the full version of the interview. As a woman business leader, what are some of the challenges you have encountered in getting to the top and how were … Continue reading Crusader for Affordable Healthcare
The last 70 years have been transformational for the Indian biotech industry, mirroring the nation’s own rapidly advancing economy and rising global status. We have successfully leveraged recombinant DNA technology to deliver biopharmaceuticals, vaccines, genetically engineered crops and enzymes. In doing so, we have created a notable bio-economy valued at $35 billion. We have embraced … Continue reading India To Be A Biotech Hot Spot
A couple of years ago, India celebrated the success of its first Mars mission and I was very excited to see the smiling faces of the women staff of Indian Space Research Organization (ISRO) being splashed all over the media. It was a watershed moment as far as the Indian Space Program is concerned. But, … Continue reading Smart Women Pursuing Smart Science
The new fiscal year promises exciting opportunities for the Indian economy, which is scheduled to bring in a game-changing new reform in the form of the Goods & Services Tax. Expectations of wider economic reforms, new measures to improve the ease of doing business in India and higher infrastructure investments also augur well for the … Continue reading Digital India Can Propel Us to Double-Digit Growth
To download the complete article, visit: http://bit.ly/2ncVkXM
2016 was a landmark year for India as demonetisation nudged the country towards an inclusive, less-cash dependant, digital future. In 2017, the government should push for the increased adoption of technology to transform the country’s public healthcare system and ensure a healthy future for all Indians. The low priority accorded to healthcare in India over … Continue reading eHealth Push Can Build a ‘Swastha Bharat’ in 2017
2016 was a landmark year for the biotechnology industry as it was for the first time that the revolutionary CRISPR-Cas9 gene-editing technique was used in humans. With more human trials involving CRISPR-Cas9 scheduled to be conducted, I believe 2017 will be the year when the technology’s potential to treat human diseases could receive strong clinical … Continue reading CRISPR: A Game Changing Technology for a More Equitable Future
Over the past month, I have been a silent spectator, witnessing a miserable drama unfold in Bangalore. This is regarding a remarkable project to safeguard an important art collection through the upkeep and modernisation of an ailing state gallery the Venkatappa Art Gallery (VAG), by turning it into a new museum for the city. These plans … Continue reading What Price Philanthropy?
When you can’t tax the rich, tax the less well-off. This is exactly what the Karnataka government did by notifying all hospitals to collect 8% luxury tax from every patient in an intensive care unit (ICU). Lying on an ICU bed fighting for one’s life is not a luxury by any stretch. But the room … Continue reading Can healthcare costs in India come down further?